7Baggers
 Mineralys completes enrollment in phase 2 sleep apnea drug trial By Investing.com  Investing.com Nigeria Wed, 01 Oct 2025 06:37:04 GMT
 mineralys at stifel forum: lorundrostat’s strategic path  Investing.com India Tue, 30 Sep 2025 19:39:51 GMT
 mineralys therapeutics completes enrollment in phase 2  GlobeNewswire Tue, 30 Sep 2025 12:21:41 GMT
 mineralys therapeutics prices $175m stock offering  MSN Mon, 29 Sep 2025 12:35:45 GMT
 strs ohio takes position in mineralys therapeutics, inc. $mlys  MarketBeat Wed, 24 Sep 2025 09:39:46 GMT
 why replimune stock plummeted by almost 40% today  AOL.com Mon, 22 Sep 2025 21:13:49 GMT
 published on: 2025-09-22 12:36:18  newser.com Mon, 22 Sep 2025 17:36:18 GMT
 mineralys therapeutics  The Pharma Letter Mon, 22 Sep 2025 07:00:00 GMT
 MLYS Stock Price and Chart — NASDAQ:MLYS  TradingView Sun, 21 Sep 2025 07:00:00 GMT
 mineralys therapeutics hits new 52-week high at $40.33, up 195%  Markets Mojo Sat, 20 Sep 2025 01:57:43 GMT
 3 potential biotech acquisition targets  Seeking Alpha Fri, 19 Sep 2025 16:53:53 GMT
 movement recap: what’s mineralys therapeutics inc.’s historical return  خودرو بانک Fri, 19 Sep 2025 02:03:30 GMT
 why replimune stock plummeted by almost 40% today  AOL.com Thu, 18 Sep 2025 23:27:49 GMT
 mineralys therapeutics  The Pharma Letter Thu, 18 Sep 2025 12:39:24 GMT
 Mineralys Therapeutics stock hits all-time high at 39.23 USD  Investing.com Thu, 18 Sep 2025 07:00:00 GMT
 mineralys therapeutics  The Pharma Letter Wed, 17 Sep 2025 07:00:00 GMT
 Mineralys Therapeutics chief medical officer sells $409k in shares  Investing.com Tue, 16 Sep 2025 07:00:00 GMT
 sa asks: which biotechs could be acquired by year's end?  Seeking Alpha Sat, 13 Sep 2025 20:18:46 GMT
 aldosterone synthase inhibitors market outlook (2025-2032) :  openPR.com Wed, 10 Sep 2025 11:44:43 GMT
 mineralys therapeutics reaches analyst target price  Nasdaq Wed, 10 Sep 2025 10:47:00 GMT
 mineralys therapeutics stock hits all-time high at 37.42 usd by investing.com  Investing.com Australia Wed, 10 Sep 2025 08:12:31 GMT
 tuesday 9/9 insider buying report: mlys, kmts  Nasdaq Tue, 09 Sep 2025 14:33:00 GMT
 is summit therapeutics a buy, sell, or hold now?  AOL.com Tue, 09 Sep 2025 10:18:39 GMT
 mineralys therapeutics stock hits all-time high at 37.42 usd  Investing.com Tue, 09 Sep 2025 07:00:00 GMT
 why mineralys therapeutics stock is climbing  TipRanks Tue, 09 Sep 2025 07:00:00 GMT
 why hecla mining stock zoomed 12% higher today  AOL.com Mon, 08 Sep 2025 22:39:23 GMT
 ra capital healthcare fund buys mineralys therapeutics shares for $30m  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 mineralys therapeutics shares surge on promising trial results  TipRanks Mon, 08 Sep 2025 07:00:00 GMT
 mineralys therapeutics (nasdaq:mlys) price target raised to $26.00  MarketBeat Mon, 08 Sep 2025 07:00:00 GMT
 mineralys reports positive subgroup data for hypertension drug by investing.com  Investing.com Canada Sat, 06 Sep 2025 08:28:03 GMT
 mineralys therapeutics closes $287.5 million public offering by investing.com  Investing.com Australia Fri, 05 Sep 2025 16:05:28 GMT
 here's why shares in ptc therapeutics soared this week  AOL.com Fri, 05 Sep 2025 13:12:45 GMT
 main line firm raises $287.5 million in stock offering exceeding ipo  The Business Journals Fri, 05 Sep 2025 07:00:00 GMT
 mineralys therapeutics shares surge on promising drug trials  TipRanks Fri, 05 Sep 2025 07:00:00 GMT
 mineralys reports positive subgroup data for hypertension drug  Investing.com Fri, 05 Sep 2025 07:00:00 GMT
 mineralys therapeutics announces closing of upsized $287.5  GlobeNewswire Fri, 05 Sep 2025 06:40:18 GMT
 jefferies raises mineralys therapeutics stock price target to $26 from $15  Investing.com Nigeria Thu, 04 Sep 2025 09:42:13 GMT

Mineralys Therapeutics, Inc.
(NASDAQ:MLYS) 

MLYS stock logo

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase in...

Founded: 2019
IPO Price: $16 (Feb 10, 2023)
CEO: Jon Congleton  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends